Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Inventory (2018 - 2025)

Marimed has reported Inventory over the past 8 years, most recently at $36.6 million for Q4 2025.

  • Quarterly Inventory rose 9.3% to $36.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.6 million through Dec 2025, up 9.3% year-over-year, with the annual reading at $36.6 million for FY2025, 9.3% up from the prior year.
  • Inventory was $36.6 million for Q4 2025 at Marimed, down from $40.0 million in the prior quarter.
  • Over five years, Inventory peaked at $40.0 million in Q3 2025 and troughed at $7.5 million in Q1 2021.
  • The 5-year median for Inventory is $24.5 million (2023), against an average of $24.1 million.
  • Year-over-year, Inventory soared 174.5% in 2021 and then grew 9.3% in 2025.
  • A 5-year view of Inventory shows it stood at $9.8 million in 2021, then surged by 99.4% to $19.5 million in 2022, then increased by 29.93% to $25.3 million in 2023, then surged by 32.33% to $33.5 million in 2024, then grew by 9.3% to $36.6 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Inventory are $36.6 million (Q4 2025), $40.0 million (Q3 2025), and $38.8 million (Q2 2025).